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a  b  s  t  r  a  c  t
Aconitum  ﬂavum  Hand.-Mazz.,  Ranunculaceae,  has been  used  for  the  treatment  of rheumatism,  trau-
matic  injury  in  folk  and  clinical  medicine,  but the  alkaloids  has  high  toxicity.  This  study  was  designed
to  investigate  the  acute  toxicity,  anti-inﬂammatory  and  antinociceptive  activities  of non-alkaloids  frac-
tions from  A. ﬂavum  in  rodents.  The  anti-inﬂammatory  activity  was  evaluated  by inﬂammatory  models
of  dimethylbenzene-induced  ear  vasodilatation  and  acetic  acid-induced  capillary  permeability  enhance-
ment  test  in mice  and carrageenan-induced  paw  edema  in rats  whereas  the  antinociceptive  activity  was
evaluated  using  acetic  acid-induced  writhes,  hot  plate  test  and  formalin  test in  mice. The  result  showed
that  the  LD50 value  of BtOH  and  EtOAc  fractions  could  not  be  determined  as  no  lethality  was  observed  up
to 40  g/kg  (p.o.)  in mice.  BtOH  fraction  signiﬁcantly  decreased  the  dimethylbenzene-induced  ear vasodil-
atation,  carrageenan-induced  paw  edema  and  acetic  acid-induced  capillary  permeability.  EtOAc  fraction
only signiﬁcantly  attenuated  paw edema  and  capillary  permeability  at the  dose  of 500 mg/kg.  In antinoci-
ceptive  test,  BtOH  and  EtOAc  fractions  signiﬁcantly  reduced  the writhing  number  evoked  by acetic  acid
injection  and  the  licking  time  in  both  phases  of the formalin  test. Meanwhile  BtOH  and  EtOAc  fractions
had  signiﬁcant  effect  on hot  plate  test  after  90 min.  Our  data  indicate  that  the  BtOH  and  EtOAc  fractions  of
NAF are  no  toxicity.  BtOH  and  EtOAc  fractions  not  only  inhibit  inﬂammatory  and peripheral  inﬂammatory
pain  but  also  have  central  antinociceptive  effect.
©  2014 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
The Aconitum consisting of over 300 species are widely dis-
ributed in Asia, Europe and North America. Most of them grow
mong high altitudes in the northern hemisphere. There are 200
pecies grow in China such as Aconitum kusnezofﬁi Reichb., Aconi-
um carmichaelithe Debx. and Aconitum ﬂavum Hand. –Mazz. (Xiao,
006). In traditional Chinese medicine, Aconitum have similar
harmacological actions and are commonly applied for various
nﬂammatory diseases, such as rheumatic fever, painful joints,
astroenteritis, diarrhea, edema, bronchial asthma and various
umors (Qin et al., 2012; Singhuber et al., 2009). However, with
he increasing popularity, Aconitum poisoning can occur in many
arts of the world. Because the highly toxic and narrow margin of
∗ Corresponding author at: 1160 Shengli street, Xingqing District, Yinchuan City,
ingxia, China.
E-mail: fuxueyan2661@163.com (X. Fu).
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s ﬁrst author.
http://dx.doi.org/10.1016/j.bjp.2014.11.013
102-695X/© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editorasafety between therapeutic and toxic doses of these herbs. Lots of
researches showed that the effects and severe toxicity of Aconitum
are mainly attributed to alkaloids (Chan, 2012; Singhuber et al.,
2009). Aconitine, mesaconitine, hypaconitine and other alkaloids
have potent cardiotoxins and neurotoxins found in all parts of the
Aconitum species, especially in the tubers and roots. Patients with
Aconitum poisoning often present with a combination of cardiovas-
cular, neurological, gastrointestinal and other signs and symptoms.
The estimated lethal dose is 2 mg  of aconitine, 5 ml  of aconite tinc-
ture (herbal medicinal wine) and 1 g of the raw aconite plant (Chan,
2012; Qin et al., 2012). Facing this dangerous situation, the effects
of non-alkaloids fraction are worth to explore, although the alka-
loids of Aconitum species were been seen as important components
in disease treatment. Modern Chinese medicine theory has been
suggested that the chemical constituents of traditional Chinese
medicine are complex and many different kinds of chemical com-
positions may  treat the diseases in similar way by additive and
synergy effect (Tu et al., 2012; Xu et al., 2014a). This theory urged
us to explore the effects of non-alkaloids fraction from Aconitum.
A. ﬂavum Hand.-Mazz. from the family Ranunculaceae, is widely
used in western China (Shanxi, Ningxia, Gansu, Inner Mongolia,
 Ltda. All rights reserved.
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inghai and Tibet). It has been used for the treatment of rheuma-
ism, traumatic injury and toothache in folk and clinical medicine
Ting et al., 2008). To date, Chinese modern research about A. ﬂavum
s mainly concentrated in pharmacological functions and quality
ontrol of alkaloids and different processed products (the toxicity
f these products was reduced by decomposing the diester diter-
ene alkaloids to the less toxic monoester diterpene alkaloids).
owever, there has been little research on anti-inﬂammatory and
ntinociceptive activity of non-alkaloids fractions from A. ﬂavum.
he aim of the present study is to evaluate the anti-inﬂammatory
nd analgesic effects of non-alkaloids fractions from A. ﬂavum in
tandard rodent models of inﬂammation and pain. Additionally, we
lso studied acute oral toxicity of the non-alkaloids fractions. These
tudies will show a direction of ﬁnding low toxic compounds from
conitum.
aterials and methods
erbal preparation and extraction
The roots of Aconitum ﬂavum Hand.-Mazz., Ranunculaceae, were
urchased from an Herbal Medicinal Materials Company of Mingde
harmaceutical Co., Ltd (Ningxia, China). The Plant is growing in
iupan mountain, Longde, Guyuan, Ningxia, China. The roots were
arvest in August to September. The plant sample was  authen-
icated by Lin Dong at Pharmacognosy Department, College of
harmacy, Ningxia Medical University, and a voucher specimen
as deposited in the same unit (Herbarium number: 20130924).
Sliced dried roots (3.7 kg) were extracted three times with 70%
thanol (mass ratio of solid to liquid was 1:10). The extract was
hen combined and evaporated to dryness under reduced pressure,
hich yielded 925 g crude extract. The crude extract was  dissolved
n 20% (v/v) ethanol aqueous (2 l), and then diluted with a solution
5000 l) of hydrochloric acid 1% in 20% ethanol aqueous. The 001 × 7
trong acid polystyrene cation exchange resin (Anhui Sanxing Resin
echnology Co., Ltd., China) were selected for further work. The
ample solution was absorbed in column with a 20 ml/min ﬂow
ate. Then column was washed with deionized water until the
fﬂuent was colorless. The combined efﬂuent was adjusted to pH
 with a solution of sodium hydroxide and evaporated using a
otary evaporator to give a non-alkaloids fraction (NAF). The NAF
as then suspended in distilled water and successively partitioned
ith petroleum ether, ethyl acetate (EtOAc) and n-butanol (BtOH)
o yield EtOAc (18.25 g) and BtOH (77.33 g) fractions, as well as an
2O residue.
stimation of the total phenolic, ﬂavonoid and saponin content
The total amount of phenolic and ﬂavonoid contents were
etermined in EtOAc and BtOH fractions using the Folin–Ciocalteu
olorimetric method and aluminum chloride colorimetric assay,
espectively. The percentage of total phenolic content expressed as
allic acid equivalents for EtOAc and BtOH fractions were 15.08%
nd 3.05%, respectively. But there have no ﬂavonoid in NAF. In addi-
ion, the saponins were measured by vanillin–perchloric acid assay.
he saponin contents expressed as oleanolic acid equivalents were
.37 and 3.83% respectively.
rugs and chemicals
The following drugs and chemicals were used: acetic acid,
imethylbenzene and formaldehyde solution were purchased from
amao Chemical Company (Tianjin, China). Carrageenan (BR; no.
1555) was from Shanghai Wanjiang Biological Technology Co.,
td. Indomethacin (no. A130602) was obtained from Shanxi Yun-
eng Pharmaceutical Co., Ltd. Evans blue (no. E2129) was purchasedrmacognosia 25 (2015) 47–52
from Sigma Co., Ltd. The fractions of NAF were suspended in water
with 0.5% (w/v) sodium carboxyl methyl cellulose (Na-CMC).
Animal preparation
The animals used in this study, including ICR mice (18–22 g;
License No.: SYXK (NING) 2011-0001) and Sprague-Dawley rats
(180–220 g; License No.: SCXK (NING) 2012-0001) were purchased
from the Experimental Animal Center of Ningxia Medical Univer-
sity (Ningxia, China). They were maintained in standard laboratory
cages, in moderate humidity (50 ± 5%), at constant temperature
(22 ± 1 ◦C) in a 12-h light–dark cycle room. All animals had free
access to food and water during the experimental period. The
experiment protocol was approved by the Ethics Committee of
Ningxia Medical University, Ningxia (Ethics approval: 2013-146).
Toxicity study
The acute toxicity study of the non-alkaloids fractions was per-
formed according to OECD guidelines (2011). The EtOAc and BtOH
fractions was  suspended in water with 0.5% (w/v) sodium carboxyl
methyl cellulose (Na-CMC) in the dose of 120, 1200, 6000, 20,000
and 40,000 mg/kg body weight were orally administered to over-
night-fasted, healthy mice (n = 8) and the animals were observed
continuously for 24 h for mortality.
Anti-inﬂammatory activity
Dimethylbenzene (DMB)-induced ear vasodilatation assay
The test was carried out according to the previously described
method (Carlson et al., 1985). Mice of either sex were ran-
domly divided in eight groups (n = 8 per group). Control
group, indomethacin (10 mg/kg, positive group), EtOAc (500
and 250 mg/kg), BtOH (500 and 250 mg/kg) and H2O (500 and
250 mg/kg) were administered via oral gavage. 60 min  after via gav-
age of test samples, the mice were topical applied 30 l DMB  to
both inner and outer surface of right ear. Mice were sacriﬁced by
cervical dislocation 30 min  later then the ear biopsies of both ears
were obtained with a punch (a diameter of 8 mm)  and weighed.
Weight-increase-rate of the right ear over the left one indicated
the vasodilatation.
Acetic acid-induced vascular permeability
The acetic acid-induced increased vascular permeability in mice
was carried out using the reported technique (Whittle, 1964).
Brieﬂy, grouping and administration were the same as mentioned
in ear vasodilatation assay. 60 min  after via gavage, 10 ml/kg body
weight of 2% Evans blue in normal saline solution to the tail vein
then applied 20 ml/kg body weight of 0.6% (v/v) acetic acid imme-
diately (i.p.). 20 min  after the administration of acetic acid, the
mice were sacriﬁced by cervical dislocation. The peritoneal cavity
was rinsed by 10 ml  of saline. The washing solutions were col-
lected in centrifuge tube and centrifuged at 1000 × g for 5 min.
The supernatant was  measured at 590 nm by spectrometry and
the absorbance of Evans blue in the exudates under 590 nm rep-
resented the capillary permeability.
Carrageenan-induced paw edema
The paw edema was induced according to Winter et al. (1962).
Animal of each sex were divided into seven groups of seven each.
They were pretreated orally with the vehicle (0.5%, w/v sodium car-
boxyl methyl cellulose, control group), EtOAc (500 and 250 mg/kg),
BtOH (500 and 250 mg/kg), H2O (500 mg/kg) and indomethacin
(10 mg/kg, p.o.). After 60 min, edema was induced with the injec-
tion of 0.1 ml  of 3% (w/v) freshly prepared carrageenan suspension
in saline into the right hind paw of each rat. The inﬂammation
a de Farmacognosia 25 (2015) 47–52 49
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Fig. 1. Effects of oral pretreatment with BtOH (500 and 250 mg/kg), EtOAc (500 and
250  mg/kg), H2O (500 and 250 mg/kg) or indomethacin (10 mg/kg) on DMB-induced
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as quantiﬁed by measuring the volume (ml) displaced by the
aw using a plethysmometer (Beijing Zhongshidichuang Science
nd Technology Development Co., Ltd, model YLS-7C, China) at 0,
, 2, 3, 4, 5 h after carrageenan injection. The edema volume was
xpressed by the variation in volume between each time (1, 2, 3, 4
nd 5 h) and basal time (0 h).
ntinociceptive activity
cetic acid-induced writhing response
Mice were used according to the method previously reported
Koster et al., 1959). The doses and the routes of administration
ere provided in ear vasodilatation assay. 60 min  after the via gav-
ge, the responses to an intraperitoneal injection of acetic acid
olution, manifesting as a contraction of the abdominal muscles
tretching of hind limbs, were counted cumulatively after 5 min
f stimulus over a period of 20 min. Nociception was induced by
ntraperitoneal injection of 0.6% acetic acid solution at the dose of
0 ml/kg body weight.
ormalin test
Formalin-induced nociception was induced in mice according
o a previously described procedure (Hunskaar et al., 1985). A vol-
me  of 20 l of a 2.5% formalin solution in saline was injected
ntraplantarly (i.pl.) in the plantar surface of the right hind paw
o mice. After formalin injection, the mice were individually placed
n a glass cylinder of 22 cm diameter and were observed from 0
o 5 min  (neurogenic pain response) and 15–30 min  (inﬂamma-
ory pain response). The time spent licking the injected paw was
ecorded with a chronometer for both phases and considered as
ndicative of nociception. The animals were pretreated with oral
oses of vehicle, indomethacin, EtOAc (500 and 250 mg/kg), BtOH
500 and 250 mg/kg) and H2O (500 and 250 mg/kg) 60 min  before
ormalin administration.
ot plate test
Mice were subjected to the hot plate test (MacDonald et al.,
946; Sahley and Berntson, 1979). A glass cylinder was placed on a
ot-plate with adjustable temperature. The temperature of the hot-
late was then regulated to 55 ± 1 ◦C. The female mice with baseline
atencies of more than 20 s were eliminated from the study and the
ut-off time of 40 s was ﬁxed to avoid damage to the paws. Each
ouse was placed in the glass on the hot-plate in order to obtain
he animal’s response to heat-induced nociceptive pain stimulus
linking of the hindpaws, jumping or shaking). The reaction times
btained at 0, 30, 60, 90 and 120 min  prior to via gavage of vehicle
nd drugs.
tatistical analysis
The results were analyzed using a statistical program SPSS
tatistics, version 17.0. One-way ANOVA followed by Dunnett’s
est was used for determining the statistically signiﬁcant differ-
nces between the values of various experimental groups. Data are
xpressed as means ± SD and p < 0.05 was considered statistically
igniﬁcant.
esults
cute toxicity studiesThe EtOAc and BtOH fractions from NAF at various dose levels
id not show any mortality, any morbid symptoms or deleterious
ffects even at the highest dose (40 g/kg, orally). The LD50 value byear  vasodilatation. The result of ear edema represents mean ± SD (n = 8). Differences
between the groups were determined by an ANOVA followed by Dunnett’s test.
*p < 0.05, **p < 0.01 when compared to the control group.
oral route could not be determined as no lethality was observed up
to 40 g/kg in mice.
Anti-inﬂammatory effects on DMB-induced ear vasodilatation
Treatment with BtOH (500 and 250 mg/kg) 1 h before applied
DMB  in mice ears signiﬁcantly (Fig. 1; p < 0.05) inhibited the edema
formation when compared to the control group. Dose-dependent
manner was  observed at BtOH groups. BtOH group at the dose
of 500 mg/kg could remarkably decrease the vasodilatation with
inhibition rate over 50%.
Anti-inﬂammatory effects on acetic acid-induced vascular
permeability enhancement250  mg/kg), H2O (500 and 250 mg/kg) or indomethacin (10 mg/kg) on the capillary
permeability under acetic acid challenge. The absorbance of Evans Blue in the leak-
age  under 590 nm represented indicated the capillary permeability. Date represents
mean ± SD (n = 8). Differences between the groups were determined by an ANOVA
followed by Dunnett’s test. *p < 0.05, **p < 0.01 when compared to the control group.
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dema. Results were obtained by oral administration of NAF fractions, indomethacin
rom  the control group were determined by ANOVA followed by Dunnett’s test. *p <
500 mg/kg, p.o.), with an inhibition of 32.13 and 27.30%, respec-
ively. The standard drug reference indomethacin resulted in a
igniﬁcant reduction (39.46%) of the control number.
nti-inﬂammatory effects on carrageenan-induced paw edema
Treatment of animals with BtOH fractions (500, 250 mg/kg, p.o.)
nd EtOAc fraction (500 mg/kg) 1 h before injection of carrageenan
igniﬁcantly (Fig. 3; p < 0.01) inhibited the edema formation at
–5 h when compared to control group. But EtOAc fraction at
ose of 250 mg/kg only signiﬁcantly decreased the edema at 1 h.
ndomethacin (10 mg/kg, p.o.) also produced a signiﬁcant inhibi-
ion of the carrageenan-induced paw edema at 1, 2, 3, 4 and 5 h
hen compared to control (Fig. 3; p < 0.01).
nti-nociceptive activity on acetic acid-induced writhes
In the acetic acid-induced writhing mice (shown in Fig. 4), EtOAc
ractions (250–500 mg/kg, p.o.) evoked a dose-dependent inhibi-
ion, the inhibitory percentage of 44.67% and 28.11%, respectively.
ll doses of EtOAc fractions signiﬁcantly (p < 0.01 and p < 0.05)
nhibited the frequency induced abdominal constrictions by acetic
cid when compared to the control group. Treatment with BtOH
raction at dose of 500 mg/kg also showed antinociceptive effect in
omparison with the control (p < 0.01).
nti-nociceptive activity on formalin test
Fig. 5 shows that both ﬁrst (neurogenic pain) and second
inﬂammatory pain) phases of formalin-induced nociception were
igniﬁcantly (p < 0.01, compared to control group) inhibited in mice
retreated orally with BtOH fractions (500, 250 mg/kg, p.o.) and
tOAc fraction (500 mg/kg). EtOAC fraction at dose of 250 mg/kg
nly signiﬁcantly (p < 0.05) inhibited the nociception at secondFig. 4. Effects of oral pretreatment with BtOH (500 and 250 mg/kg), EtOAc (500
and  250 mg/kg), H2O (500 and 250 mg/kg) or indomethacin (10 mg/kg) on acetic
acid-induced writhing in mice. Each value represents mean ± SD (n = 8). *p < 0.05,
**p < 0.01 when compared to the control group.
phase compared to control group. The inhibitions were 50.8 and
80.3% in BtOH group at the dose of 500 mg/kg, for the ﬁrst and
second phases, respectively. In contrast, indomethacin (10 mg/kg,
p.o.) only signiﬁcantly reduced the inﬂammatory (75.8%) phase of
formalin-induced nociception.
Anti-nociceptive activity on hot plate testIn the hot plate test, the results presented in Fig. 6 showed
that signiﬁcant (p < 0.01 and p < 0.05) antinociceptive effect in BtOH
fraction and EtOAc fraction groups (500 mg/kg) at 90 and 120 min
after administration when compared to control groups.
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unnett’s test compared to control group at second phase.
iscussion
The toxicity of alkaloids from Aconitum ﬂavum Hand.-Mazz,
anunculaceae, has made us worried, so to obtain nature products
ith favorable effects and low toxicity from A. ﬂavum become a
eaningful research direction. In order to realize this objective, we
tudied the non-alkaloids fractions from this herb. In our study,
01 × 7 strong acid polystyrene cation exchange resin which is
 low cross-linking resin and has porous structure was  selected
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ean  ± SD (n = 8). Differences between the groups were determined by an ANOVA followrmacognosia 25 (2015) 47–52 51
for preparing NAF. This resin may  be beneﬁcial to adsorb alkaline
high molecular weight components such as ions of alkaloids (Yang
and Kong, 2009). The ions of alkaloids were retained in chromato-
graphic column, but the non-alkaloids fractions could be washed
using deionized water. In our study, no deaths or serious clinical
signs in both EtOAc and BtOH fractions at the highest dose of 40 g/kg
(this dose is much higher than the dose of treatment) in acute tox-
icity study. Although the evidence of risk in longer use is unknown,
but the acute toxic results sufﬁciently support the fact that BtOH
and EtOAc fractions of NAF have no toxicity.
Xylene-induced ear edema in mice is a preliminary and
simple acute inﬂammation model for evaluating potential anti-
inﬂammatory agents (Cheng et al., 2005). Ear edema may involve
inﬂammatory mediators such as histamine, kinin, ﬁbrinolysin,
phospholipase A2 and PLA2. These mediators induce edema by pro-
moting vasodilation and increasing vascular permeability (Li et al.,
2011; Xu et al., 2014b). The BtOH fraction of NAF was able to reduce
inﬂammation in this model and acetic acid-induced vascular per-
meability enhancement model. These results suggest that BtOH
fraction may  interfere with the actions of inﬂammatory mediators
and produce the anti-inﬂammatory effect. Carrageenan-induced
paw edema is a largely used test for screening both steroidal
anti-inﬂammatory drugs and NSAID. The inﬂammatory response
involves three phases through sequential release of several medi-
ators. The early phase (the ﬁrst 90 min) involves the release of
histamine and serotonin; the second phase (90–150 min) is medi-
ated by kinin and the third phase (after 180 min) is mediated by
prostaglandin (Di Rosa et al., 1971). The results from this study
suggest that the BtOH and EtOAc fractions of NAF possibly act by
inhibiting the release or action of histamine, serotonin and kinin
and prostaglandin of the edema development.
The analgesic activity of NAF fractions in this study was  inves-
tigated using the abdominal writhing, formalin and hot plate tests
in mice. The writhing model induced by acetic acid in mice was
*
*
**
**
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EtoAc (250 mg/kg)
H2O (250 mg/kg)
60 90 12
0
 (min)
 mg/kg) and H2O (500 and 250 mg/kg) on hot-plate test in mice. Date represents
ed by Dunnett’s test. *p < 0.05, **p < 0.01 when compared to the control group.
5 a de Fa
c
a
d
l
s
a
e
f
e
o
v
t
a
n
p
(
w
i
(
p
p
f
o
m
t
t
i
f
a
e
c
c
a
l
s
l
w
a
A
B
t
a
a
f
c
A
r
t
Y
m
a
a
C
A
r
Chinese Medicine. Chemical Industry Press, Beijing, pp. 249–256.2 Y. Zhang et al. / Revista Brasileir
ommonly considered as classical peripheral inﬂammatory pain
nimal model for evaluation of analgestic or anti-inﬂammatory
rugs (Negus et al., 2006). The peripheral analgesic is due to the
iberation of several inﬂammatory mediators such as bradykinin,
ubstance P, prostaglandins and cyclo-oxygenases, lipoxygenases,
s well as some cytokines such as IL-1, TNF- and IL-8 (Ikeda
t al., 2001; Ribeiro and Poole, 2000). The hot plate test has been
ound suitable to evaluate centrally antinociceptive (Hiruma-Lima
t al., 2000). In order to further clarify the antinociceptive effect
f NAF fractions, the formalin test was carried out. This model is
alidly used in analgesia research (Tjølsen et al., 1992), it involves
wo phases (Zakaria et al., 2008). The ﬁrst phase (0–5 min) is char-
cterized by neurogenic pain caused by a direct stimulation of
ociceptors. Substance P and bradykinin are thought to partici-
ate in this phase (Hunskaar and Hole, 1987). The second phase
15–30 min) is characterized by inﬂammatory pain, a process in
hich several inﬂammatory mediators are believed to be involved,
ncluding histamine, serotonin, prostaglandins and bradykinin
Tjølsen et al., 1992). In general, centrally acting drugs inhibit both
hases equally, while peripherally acting drugs inhibit the second
hase (Xu et al., 2014b). As presented in Fig. 5, the BtOH and EtOAc
ractions of NAF suppressed the pain in two phases. The results
btained from the formalin test were therefore in good agree-
ent with the results from the hot-plate test and writhing test,
hereby indicating that BtOH and EtOAc fractions of NAF had cen-
ral and peripheral analgesic property. These results obtained from
nﬂammation and pain animal model conﬁrm that BtOH and EtOAc
ractions could inhibition of the production of inﬂammatory medi-
tors such as histamine, serotonin, prostaglandins and bradykinin.
Although this research obtained meaningful results, it still
xisted many problems worth us thinking and improving. The
hemical compositions of BtOH and EtOAc fractions are not very
lear. Together with previous studies, the constituents of Aconitum
lso include ﬂavonoids, phenolic acids and saponins besides alka-
oids (Shrestha et al., 2006; Wuljitegus et al., 2008). The ﬂavonoids,
aponins and phenolic acids in those two NAF fractions were ana-
yzed by ultraviolet spectrophotometry in our study. No ﬂavonoids
ere identiﬁed in those two fractions. However the phenolic acids
nd saponins gave a 15.08 and 9.73 percent in EtOAc fractions.
t the same time, the phenolic acids and saponins percentage of
tOH fraction were 3.05% and 3.83%. With reference to the results
hat EtOAc and BtOH fractions of NAF have anti-inﬂammatory and
ntinociceptive effects at high dose, we can speculate that the
nti-inﬂammatory and antinociceptive effects of EtOAc and BtOH
ractions may  be attributed to chemical components with low con-
entration, such as phenolic acids and saponins.
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